UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
UroGen Pharma (URGN) - Total assets
Total assets on the balance sheet as of December 2023 : $0.17 B
According to UroGen Pharma's latest financial reports the company's total assets are $0.17 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
UroGen Pharma - Total assets on balance sheet (from 2016 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | 31.48% |
| 2022-12-31 | $0.13 B | 13.26% |
| 2021-12-31 | $0.11 B | -1.85% |
| 2020-12-31 | $0.12 B | -39.72% |
| 2019-12-31 | $0.20 B | 95.43% |
| 2018-12-31 | $0.10 B | 37.07% |
| 2017-12-31 | $75.55 M | 227.68% |
| 2016-12-31 | $23.05 M | 18.91% |
| 2015-12-31 | $19.39 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | 41.33% | 🇺🇸 USA |